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Manufacturers of therapeutic proteins are becoming increasingly interested in continuous bioprocessing. Via 
uninterrupted medium exchange, perfusion cell culture yields higher volumetric productivity than traditional 
batch/fed-batch processes with 2 to 5 fold higher cell density and cultivation duration. In addition, an 
uninterrupted removal of therapeutic proteins promotes a desired alignment with integrated continuous 
purification processes to eliminate large hold tanks.  
 
Hollow fiber tangential flow filtration (TFF) is commonly used for cell retention in perfusion cell culture. In these 
perfusion systems the major limitation can be inefficient or decaying product sieving. This increases product’s 
retention time in the bioreactor, which may detrimentally affect the target protein quality attributes and decrease 
yield.   
 
Herein, three commercially available TFF membranes are employed in high cell density CHO perfusion for more 
than 21 culture days. This work highlights the learnings obtained from interrogating various filter characteristics 
(e.g., pore size, chemistry) as well as operating conditions. The resulting understanding led to a solution with 
high mass transfer (>90% sieving) and particle free permeate stream (turbidity <10 NTU) to allow direct loading 
of a chromatography capture step. This work not only showcases a TFF perfusion toolbox, but also 





Figure 1 – TFF perfusion evolution to overcome product sieving.   
